# Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

> **NCT00162292** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 33 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** BMS-582949 and Methotrexate

## Key facts

- **NCT ID:** NCT00162292
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162292, "Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00162292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*